ENTITY

MorphoSys AG (MOR GR)

13
Analysis
Health CareGermany
MorphoSys AG operates as a biopharmaceutical company. The Company discovers and develops differentiated therapies and medicines for the patients suffering from cancer, inflammations, and autoimmune diseases. MorphoSys serves customers in Germany.
more
Refresh
Exchange Announcement17 Nov 2022 21:00
Exchange Announcement04 Aug 2022 16:49
Exchange Announcement05 May 2022 16:49
Exchange Announcement16 Mar 2022 08:00
Exchange Announcement11 Nov 2021 08:00
x